Minnesota HF4064: Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.

What the bill says

A bill for an act relating to health; directing the commissioner of health to study and report on activities to support innovations in cell and gene therapy to treat rare diseases; requiring a report; appropriating money.

From the introduced text, March 6, 2026:

A bill for an act relating to health; directing the commissioner of health to study and report on activities to support innovations in cell and gene therapy to treat rare diseases; requiring a report; appropriating money. Section 1. new text begin [ADDED: STUDY AND REPORT ON ACTIVITIES TO SUPPORT INNOVATIONS IN CELL AND GENE THERAPIES TO TREAT RARE DISEASES.] new text end new text begin [ADDED: Subdivision 1.] new text end new text begin [ADDED: Legislative intent.] new text end new text begin [ADDED: The legislature finds that the development of cell and gene therapies offers significant promise to treat and potentially cure a wide range of diseases, including cancer, rare genetic disorders, and autoimmune conditions. The legislature recognizes that the state of Minnesota is a national leader in biomedical research and health care innovation and recognizes the importance of fostering scientific progress and promoting economic development in cell and gene therapy.] new text end new text begin [ADDED: Subd. 2.] new text end new text begin [ADDED: State policy.] new text end new text begin [ADDED: It is the policy of the state of Minnesota to support and encourage the advancement, commercialization, and clinical translation of new technologies and applications in the fields of cell and gene therapy. These activities include but are not limited to research and development …

Read the full official text

Sponsors

• Liz Reyer (D) · primary sponsor
• Athena Hollins (D)
• Anquam Mahamoud (D)
• Bianca Virnig (D)
• Kaela Berg (D)
• Danny Nadeau (R)
• Mike Freiberg (D)
• Robert Bierman (D)
• Jeff Backer (R)
• Paul Torkelson (R)

Latest actions

1. April 20, 2026: Author added Torkelson
2. March 9, 2026: Introduction and first reading, referred to Health Finance and Policy

Common questions

What is HF4064?

HF4064 is a bill in the Minnesota Legislature (94th Legislature 2025-2026): Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.

What does HF4064 do?

In its own words: A bill for an act relating to health; directing the commissioner of health to study and report on activities to support innovations in cell and gene therapy to treat rare diseases; requiring a report; appropriating money.

What is the status of HF4064?

In committee as of April 20, 2026. Latest action: Author added Torkelson (April 20, 2026).

Who sponsored HF4064?

Liz Reyer (D), with 9 co-sponsors.

Where is the official record for HF4064?

On the Minnesota Legislature website: https://www.revisor.mn.gov/bills/bill.php?f=HF4064&y=2025&ssn=0&b=house